Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects

✍ Scribed by Christoph Mundhenke; Marion Tina Weigel; Klarissa Hanja Sturner; Frank Roesel; Ivo Meinhold-Heerlein; Dirk O. Bauerschlag; Christian Schem; Felix Hilpert; Walter Jonat; Nicolai Maass

• Publisher: Springer-Verlag
• Year: 2008
• Tongue: English
• Weight: 505 KB
• Volume: 134
• Category: Article
• ISSN: 1432-1335
• DOI: 10.1007/s00432-008-0408-0